Healthcare M&A Deal Volume & Size Bottom Out in First Quarter
Healthcare M&A might have bottomed out in the first quarter of 2022 in terms of both deal volume and size, according to a new report.
Deals-lir
Subscribe today for full access
to all of these articles.
Latest Articles
Onco Pharma Giants Team Up to Boost Access to Cancer Genomic Testing
The recently-formed Precision Cancer Consortium will make it easier for cancer patients around the world to get access to genomic testing.
The Craze Is Over but Health Care SPAC Deals Remain Alive and Well
A hot trend in capital raising for the health care and life sciences only two years ago, SPAC deals have petered out, but are far from dead.
Partnership to Create New Tool for Rapid SARS-CoV-2 Variant Detection
Thermo Fisher, Helix, and Rosalind collaborate on an NIH-supported project to develop a new genotyping method to ID virus variants faster.
